Alessandra Balduzzi

1.3k total citations
35 papers, 1.0k citations indexed

About

Alessandra Balduzzi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alessandra Balduzzi has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alessandra Balduzzi's work include Breast Cancer Treatment Studies (24 papers), Cancer Treatment and Pharmacology (14 papers) and HER2/EGFR in Cancer Research (12 papers). Alessandra Balduzzi is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Cancer Treatment and Pharmacology (14 papers) and HER2/EGFR in Cancer Research (12 papers). Alessandra Balduzzi collaborates with scholars based in Italy, Switzerland and United States. Alessandra Balduzzi's co-authors include Marco Colleoni, Aron Goldhirsch, Paolo Veronesi, Giuseppe Viale, Alberto Luini, R. Ghisini, Anna Cardillo, Rosalba Torrisi, Emilia Montagna and Laura Orlando and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Molecular Pharmacology.

In The Last Decade

Alessandra Balduzzi

34 papers receiving 990 citations

Peers

Alessandra Balduzzi
M. Piccart-Gebhart Belgium
Hans Halfwerk Netherlands
Anna Cardillo Italy
I. E. Smith United Kingdom
Atsushi Shimomura Japan
Yoshiaki Rai Japan
K. David Voduc Canada
JFR Robertson United Kingdom
Chikako Shimizu Japan
S. Ashley United Kingdom
M. Piccart-Gebhart Belgium
Alessandra Balduzzi
Citations per year, relative to Alessandra Balduzzi Alessandra Balduzzi (= 1×) peers M. Piccart-Gebhart

Countries citing papers authored by Alessandra Balduzzi

Since Specialization
Citations

This map shows the geographic impact of Alessandra Balduzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Balduzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Balduzzi more than expected).

Fields of papers citing papers by Alessandra Balduzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Balduzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Balduzzi. The network helps show where Alessandra Balduzzi may publish in the future.

Co-authorship network of co-authors of Alessandra Balduzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Balduzzi. A scholar is included among the top collaborators of Alessandra Balduzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Balduzzi. Alessandra Balduzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montagna, Emilia, Vincenzo Bagnardi, Giulia Viale, et al.. (2014). Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy. Annals of Oncology. 26(2). 307–313. 40 indexed citations
2.
Balduzzi, Alessandra, Vincenzo Bagnardi, Nicole Rotmensz, et al.. (2013). Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression. Clinical Breast Cancer. 14(4). 258–264. 45 indexed citations
3.
Cancello, Giuseppe, Patrick Maisonneuve, Nicole Rotmensz, et al.. (2012). Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse. Annals of Oncology. 24(3). 661–668. 90 indexed citations
4.
Montagna, Emilia, Patrick Maisonneuve, Nicole Rotmensz, et al.. (2012). Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome. Clinical Breast Cancer. 13(1). 31–39. 114 indexed citations
5.
Montagna, Emilia, Vincenzo Bagnardi, Nicole Rotmensz, et al.. (2011). Breast cancer subtypes and outcome after local and regional relapse. Annals of Oncology. 23(2). 324–331. 51 indexed citations
6.
Balduzzi, Alessandra, Maria Cristina Leonardi, Anna Cardillo, et al.. (2010). Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treatment Reviews. 36(6). 443–450. 24 indexed citations
7.
Iorfida, Monica, Vincenzo Bagnardi, Alessandra Balduzzi, et al.. (2010). Preoperative therapy with trastuzumab and oral vinorelbine (± endocrine therapy) in patients with HER2-positive breast cancer. The Breast. 19(2). 128–132. 5 indexed citations
8.
9.
Montagna, Emilia, Vincenzo Bagnardi, Nicole Rotmensz, et al.. (2010). Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features. Breast Cancer Research and Treatment. 124(3). 689–699. 58 indexed citations
10.
Torrisi, Rosalba, Silvia Dellapasqua, R. Ghisini, et al.. (2008). Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors. The Breast. 17(6). 654–660. 7 indexed citations
11.
12.
D’Alessandro, Claudia, Silvia Dellapasqua, Laura Orlando, et al.. (2008). Role of Endocrine Responsiveness and HER2/neu Overexpression in Inflammatory Breast Cancer Treated with Multimodality Preoperative Therapy. The Breast Journal. 14(5). 435–441. 5 indexed citations
13.
Colleoni, Marco, Giuseppe Viale, David Zahrieh, et al.. (2007). Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Annals of Oncology. 19(3). 465–472. 82 indexed citations
14.
Curigliano, Giuseppe, Alessandra Balduzzi, Anna Cardillo, et al.. (2007). Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter. Supportive Care in Cancer. 15(10). 1213–1217. 10 indexed citations
15.
Torrisi, Rosalba, Alessandra Balduzzi, R. Ghisini, et al.. (2007). Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. Cancer Chemotherapy and Pharmacology. 62(4). 667–672. 75 indexed citations
16.
Rocca, Andrea, Giuseppe Viale, Richard D. Gelber, et al.. (2007). Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression. Cancer Chemotherapy and Pharmacology. 61(6). 965–971. 18 indexed citations
17.
Prete, Salvatore Pasquale, Stefania D’Atri, Grazia Graziani, et al.. (2006). BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression. International Immunopharmacology. 7(3). 321–332. 5 indexed citations
18.
Orlando, Laura, Anna Cardillo, R. Ghisini, et al.. (2006). Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer. BMC Cancer. 6(1). 225–225. 96 indexed citations
19.
Balduzzi, Alessandra & Monica Castiglione‐Gertsch. (2005). Leukemia risk after adjuvant treatment of early breast cancer. Women s Health. 1(1). 73–85. 4 indexed citations
20.
Tentori, Lucio, Ilaria Portarena, Marcella Barbarino, et al.. (2003). Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor. Molecular Pharmacology. 63(1). 192–202. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Piccart-Gebhart Breakdown of academic impact, for papers by Hans Halfwerk Breakdown of academic impact, for papers by Anna Cardillo Breakdown of academic impact, for papers by I. E. Smith Breakdown of academic impact, for papers by Atsushi Shimomura Breakdown of academic impact, for papers by Yoshiaki Rai Breakdown of academic impact, for papers by K. David Voduc Breakdown of academic impact, for papers by JFR Robertson Breakdown of academic impact, for papers by Chikako Shimizu Breakdown of academic impact, for papers by S. Ashley
Rankless by CCL
2026